Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00168090
Status:
COMPLETED
Last Update Posted:
2011-02-11
First Post:
2005-09-12
Brief Title:
Study of Safety and Efficacy of Antihemophilic FactorVon Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease vWD
Sponsor:
CSL Behring
Organization:
CSL Behring
Study Overview
Official Title:
Study of Safety and Efficacy of Antihemophilic FactorVon Willebrand Factor Complex Humate-P Using Individualized Dosing in Pediatric and Adult Surgical Subjects With Von Willebrands Disease
Status:
COMPLETED
Status Verified Date:
2011-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to test the safety and effectiveness of Humate-P to prevent bleeding in patients with von Willebrand Disease who are undergoing surgery
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None